SUPN

SUPERNUS PHARMACEUTICALS INC

Healthcare | Mid Cap

$0.19

EPS Forecast

$195.4

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

$0.19

Revenue Forecast:

$195.4

EPS Surprise Forecast:

$0.078

Revenue Surprise Forecast:

$7

Post-release price volatility - High

Post-release Overnight Move:

±7.8%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

79%

Probability of beating revenue consensus:

79%

Probability of beating both EPS & revs consensus:

66%

Probability of missing both EPS & revs consensus:

9%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

2

Beta (β)

Forward Looking Beta (β):

1.20

Earnings volatility

EPS standard deviation:

$0.22

Revenue standard deviation:

$19

As % of share price:

0.46% MEDIUM

As % of market cap:

0.68% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$0.48

Revenue 95th %ile:

$220

EPS 75th %ile:

$0.27

Revenue 75th %ile:

$202

EPS 25th %ile:

$0.13

Revenue 25th %ile:

$190

EPS 5th %ile:

-$0.05

Revenue 5th %ile:

$175

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

43% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

29% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$20

Bid-ask per Share:

$0.1